Endovascular intervention for treatment of claudication: is it cost-effective?

Annals of Vascular Surgery
Timothy M SullivanMaciej L Dryjski

Abstract

Treatment of claudication with endovascular intervention (EVI), a procedure designed to enhance quality of life, is on the rise despite being expensive. We examined clinical outcomes and costs for treatment of claudication with EVI. Records of all EVI performed at a University Health Center during a single year were reviewed for functional capacity, Trans-Atlantic Inter-Society Council (TASC) classification, procedure, reintervention, and financial data. Sustained clinical success (SCS) (improvement without target extremity revascularization [TER]) and secondary sustained clinical success (SSCS) (improvement with TER) were tracked over 2 years follow-up. There were 77 patients (90 limbs). Mean follow-up was 14.8 +/- 7.7 months (1-30). Procedural success was 94%. Two-year SCS and SSCS were found to be 28 +/- 9% and 49 +/- 11%, respectively. SCS differed significantly from TASC (p = 0.02), whereas SSCS did not (p = 0.33). Mean time to reintervention was 11.7 +/- 6.6 months. Two-year TER-free rate (65 +/- 7%) did not differ significantly by procedure (p = 0.26), the artery treated (p = 0.24), or TASC (p = 0.18). Two-year costs for EVI were $13,886, differing significantly by TASC (p = 0.017) and by the artery treated (p < 0.001). ...Continue Reading

References

Sep 27, 1995·JAMA : the Journal of the American Medical Association·A W Gardner, E T Poehlman
Mar 4, 1999·The New England Journal of Medicine·D E JorenbyT B Baker
Dec 13, 2002·The New England Journal of Medicine·Kerry J StewartAlan T Hirsch
Jul 9, 2005·Journal of Vascular and Interventional Radiology : JVIR·Timothy P MurphyRichard A Haas
Jan 16, 2007·Journal of Vascular Surgery·L NorgrenUNKNOWN TASC II Working Group
Feb 26, 2008·Journal of Vascular Surgery·Monica S O'Brien-IrrMaciej L Dryjski
Apr 29, 2008·Journal of Vascular Surgery·Timothy P MurphyUNKNOWN CLEVER Steering Committee
May 6, 2008·Journal of Vascular Surgery·Anna LetterstålEric Wahlberg
Nov 26, 2008·Journal of Vascular Surgery·Lotte M KruidenierJoep A W Teijink

❮ Previous
Next ❯

Citations

Jun 22, 2014·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·H J P FokkenroodJ A W Teijink
May 3, 2011·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·M L Dryjski
Aug 7, 2014·Circulation·Ryan J Mays, Judith G Regensteiner
Aug 15, 2019·Vascular Medicine·Sherene E SharathNeal R Barshes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Vascular Surgery
Monica S O'Brien-IrrMaciej L Dryjski
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
I Stolyarova, V Vinokurov
Zhurnal mikrobiologii, epidemiologii, i immunobiologii
A V SevostianovaT A Kirillova
© 2021 Meta ULC. All rights reserved